Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

INSP PEER ANALYSIS

Inspire Medical Systems Inc — metric-by-metric comparison with peers and the industry median

INSPInspire Medical Systems Inc

🇺🇸 USA · NYSE · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
INSPIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
INSP-61.5%4DX+1,679.6%COH-56.7%SN+4.6%ONCSM+203.3%MEDTR-8.2%
Year-to-Date (YTD)
INSP-46.4%4DX+10.9%COH-50.3%SN-6.9%ONCSM-4.8%MEDTR+0.3%
1-Year
Split-adjusted
INSP-61.5%ATEC-15.1%IART+34.8%IRMD+67.8%ENOV-23.0%QDEL-40.4%
Year-to-Date (YTD)
INSP-46.4%ATEC-55.7%IART+46.4%IRMD+5.6%ENOV-2.8%QDEL-37.0%

Key Metric Comparison

P/E

Lower is better
INSP10.824DX—COH24.27SN20.73ONCSM122.41MEDTR596.83Median 26.82

ROE

Higher is better
INSP18.4%4DX—COH18.1%SN12.1%ONCSM12.9%MEDTR0.2%Median -8.6%

Net Margin

Higher is better
INSP14.3%4DX-3,684.6%COH14.6%SN10.1%ONCSM6.3%MEDTR0.2%Median -5.7%

Revenue Growth

Higher is better
INSP8.9%4DX-26.0%COH2.0%SN—ONCSM39.1%MEDTR6.5%Median 7.4%

P/E

Lower is better
INSP10.82ATEC—IART—IRMD55.76ENOV—QDEL—Median 26.82

ROE

Higher is better
INSP18.4%ATEC—IART-38.6%IRMD25.0%ENOV-55.5%QDEL-49.9%Median -8.6%

Net Margin

Higher is better
INSP14.3%ATEC-15.9%IART-30.1%IRMD27.4%ENOV-49.9%QDEL-45.6%Median -5.7%

Revenue Growth

Higher is better
INSP8.9%ATEC22.5%IART1.2%IRMD14.8%ENOV6.0%QDEL-3.9%Median 7.4%

All Metrics

Valuation
MetricINSP4DXCOHSNONCSMMEDTRInd. Median
P/E10.82●—24.2720.73122.41596.8326.82
P/B1.79-76.08●4.322.5013.361.082.50
EV/EBITDA14.54—15.209.94●25.4610.9315.54
P/S1.55249.463.552.107.661.18●2.69
Financial Health
MetricINSP4DXCOHSNONCSMMEDTRInd. Median
Current Ratio6.346.57●2.462.572.253.583.28
Debt/Equity3.7%-22.6%●22.1%62.9%35.0%1.0%44.7%
NetDebt/EBITDA-3.17●0.710.421.720.42-1.640.82
Profitability
MetricINSP4DXCOHSNONCSMMEDTRInd. Median
Net Margin14.3%-3,684.6%14.6%●10.1%6.3%0.2%-5.7%
ROE18.4%●—18.1%12.1%12.9%0.2%-8.6%
ROA16.0%●-264.3%12.4%6.1%8.0%0.2%-6.4%
EBITDA Margin8.8%-818.8%24.0%25.6%30.6%●9.4%5.2%
Growth + Dividend
MetricINSP4DXCOHSNONCSMMEDTRInd. Median
Rev. Growth8.9%-26.0%2.0%—39.1%●6.5%7.4%
NI Growth97.2%●—-6.8%——-62.9%16.7%
Div. Yield——3.6%●3.5%0.0%1.1%1.1%
Payout——81.5%52.8%0.0%656.3%39.0%
Valuation
MetricINSPATECIARTIRMDENOVQDELInd. Median
P/E10.82●——55.76——26.82
P/B1.7978.731.3413.361.000.66●2.50
EV/EBITDA14.54—————15.54
P/S1.551.830.8515.260.650.46●2.69
Financial Health
MetricINSPATECIARTIRMDENOVQDELInd. Median
Current Ratio6.341.903.387.13●2.041.433.28
Debt/Equity3.7%●3,303.4%195.6%—95.5%155.3%44.7%
NetDebt/EBITDA-3.17-341.81●-6.13—-1.84-4.980.82
Profitability
MetricINSPATECIARTIRMDENOVQDELInd. Median
Net Margin14.3%-15.9%-30.1%27.4%●-49.9%-45.6%-5.7%
ROE18.4%—-38.6%25.0%●-55.5%-49.9%-8.6%
ROA16.0%-15.8%-21.8%21.8%●-26.1%-20.0%-6.4%
EBITDA Margin8.8%-0.2%-17.6%37.4%●-32.8%-20.7%5.2%
Growth + Dividend
MetricINSPATECIARTIRMDENOVQDELInd. Median
Rev. Growth8.9%22.5%●1.2%14.8%6.0%-3.9%7.4%
NI Growth97.2%●——19.3%——16.7%
Div. Yield———0.8%——1.1%
Payout———65.4%——39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on INSP

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.